UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
CURRENT REPORT
Pursuant to Section 13
or 15(d) of the Securities Exchange Act of 1934
November 5, 2007 Date of Report (Date of earliest event reported) |
||
NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) |
||
Delaware (State or other jurisdiction of incorporation) |
001-12421 (Commission File Number) |
87-0565309 (IRS Employer Identification Number) |
75 West Center Street Provo, UT 84601 (Address of principal executive offices and zip code) (801) 345-1000 (Registrant's telephone number, including area code) N/A (Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c)) |
Item 2.02 | Results of Operations and Financial Condition. |
On November 5, 2007, Nu Skin Enterprises, Inc. (the Company) issued a press release announcing its financial results for the third quarter and nine months ended September 30, 2007, and certain other information. A copy of the Companys press release is attached as Exhibit 99.1 to this report and incorporated by reference.
The information furnished pursuant to this Item 2.02 and the exhibit hereto shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such filing.
Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibit.
99.1 | Nu Skin Enterprises press release dated November 5, 2007, regarding financial results for the third quarter and nine months ended September 30, 2007. |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
NU SKIN ENTERPRISES, INC. (Registrant) /s/ D. Matthew Dorny D. Matthew Dorny Vice President |
Date: November 5, 2007
Exhibit No. | Exhibit Description |
99.1 | Nu Skin Enterprises press release dated November 5, 2007, regarding financial results for the third quarter and nine months ended September 30, 2007. |
FOR IMMEDIATE RELEASE
CONTACTS:
Scott Pond (investors)
(801) 345-2657, spond@nuskin.com
Kara Schneck (media)
(801) 345-2116, kschneck@nuskin.com
PROVO, Utah Nov. 5, 2007 Nu Skin Enterprises, Inc. (NYSE: NUS) today reported third-quarter revenue of $290.7 million, representing a 5 percent improvement over the prior-year period. Quarterly net income and earnings per share were $13.5 million and $0.21, respectively, compared to $13.2 million and $0.19 during the same quarter of 2006. Third-quarter 2007 earnings per share include approximately $0.05 of net costs associated with the global distributor convention held in September. Revenue for the quarter was positively impacted 1 percent by foreign currency fluctuations.
Double-digit revenue gains in North America, Europe, South Korea and Southeast Asia drove overall revenue growth, said Truman Hunt, president and chief executive officer. Successful sales initiatives and greater internal and external alignment resulted in accelerated revenue growth in the third quarter. In addition, we began unifying our marketing efforts around our new global brand positioning, the difference. demonstrated. that focuses on our ability to demonstrate the Nu Skin difference through our people, products, culture and opportunity.
Additionally, our new Japan and China management teams are implementing plans to boost our business in these markets. At the end of the third quarter in Japan, we began launching aggressive sales initiatives focused on distributor recruitment. We are also energizing the personal care business in this market by re-staging the Galvanic Spa System II, which is successfully driving growth in South Korea, Europe and the United States. Similarly, our China team has begun executing changes to strengthen our business model. The enhancements to our China operations are scheduled to be fully implemented by the second quarter of 2008. We are confident in our new management teams in Japan and China and expect to see improving results, Hunt continued.
-more-
Nu Skin Enterprises
Nov. 5, 2007
Page 2
Third-quarter results brought the companys nine-month revenue total to $851.6 million compared to $826.2 million in 2006, while earnings per share for the first nine months of 2007 were $0.57 compared to $0.24 for the same 2006 period. Net income for the period was $37.8 million compared to $17.0 million in 2006. Results for 2006 included restructuring and other charges in the first quarter that negatively impacted net income and earnings per share by $32.0 million and $0.28, respectively.
North Asia. Third-quarter revenue in North Asia was $142.6 million, compared to $147.8 million for the same period in 2006. Local-currency revenue in Japan was down 7 percent on a year-over-year basis, or down 5 percent when including revenue of approximately $2.0 million from Japanese distributors at the companys global convention, that was included in U.S. results. South Korea had a solid quarter with revenue up 13 percent compared to the prior-year period. The executive and active distributor counts in the region were down 2 percent, due to declines in Japan.
Greater China. Revenue in Greater China was $52.0 million for the third quarter, representing a 2 percent increase compared to prior-year results. Taiwan and Hong Kong generated solid results with local currency revenue up 3 percent and 7 percent, respectively, while mainland China reported a 7 percent local currency revenue decline from the prior year. The executive distributor count in the region was flat compared with the third quarter of 2006, while the number of active distributors decreased 7 percent.
Americas. Revenue in the Americas was $52.5 million, including approximately $5.0 million in product revenue and convention fees from non-U.S. distributors at the companys global convention. This represents a 30 percent revenue increase over the prior-year period. Excluding sales to international distributors, revenue in the United States improved 17 percent. Executive and active distributor counts in the Americas improved 13 percent and 2 percent, respectively, over prior-year results.
-more-
Nu Skin Enterprises
Nov. 5, 2007
Page 3
South Asia/Pacific. Revenue in South Asia/Pacific increased 12 percent to $25.5 million, compared to $22.7 million in the prior year, driven by strong results throughout the region. The third-quarter executive count improved 4 percent while active distributors decreased 10 percent, compared to the same period in 2006.
Europe. Revenue from Europe was $18.1 million, a 26 percent improvement over the prior-year period. The regions results were positively impacted approximately 9 percent by foreign currency fluctuations. Executive and active distributor counts in the region increased 30 and 15 percent, respectively, compared to the prior-year period.
The companys gross margin was 82.0 percent, a 50 basis point decrease over the prior-year period. The decline is due primarily to low-margin sales aids sold at the companys global convention held in September and the shift in the geographic revenue mix. Selling expenses, as a percent of revenue, were 43.1 percent compared to 43.7 percent in the prior year.
General and administrative expenses for the quarter, as a percent of revenue, were 32.3 percent, up 110 basis points over the prior-year period. Third-quarter results included $6.8 million in expenses, or 2.3 percent of revenue, associated with the companys global convention which was not held in the prior-year period.
The companys cash and short-term investment position at the end of the quarter was $126 million and the company paid $6.8 million in dividends during the period. The effective tax rate for the quarter was 30 percent compared to 37 percent in the prior-year period. The change in effective tax rate is tied to the implementation of FIN 48, the new accounting regulation for uncertain tax positions. Earnings per share were positively impacted approximately 10 percent by stock repurchases over the last 12 months.
We look forward to outlining our 2008 plans at our annual investor conference in New York today, said Hunt. Overall, I am very encouraged by the improvement we are seeing in top-line results, and we are focused on aggressively moving forward to improve profitability. Accelerated revenue growth in the third quarter was the result of strong trends in North America, Europe, South Korea and Southeast Asia. Taiwan and Hong Kong are also performing well.
-more-
Nu Skin Enterprises
Nov. 5, 2007
Page 4
Since initiating our business transformation 24 months ago, we have taken significant steps to renew growth. We believe we have identified additional areas where we can leverage continued revenue growth to generate improvements in profitability.
In 2008, our strategic imperatives are:
| Aligning globally behind our new brand positioning. |
| Strengthening our partnership and alignment with our sales force. |
| Focusing on sponsoring new distributors. |
| Addressing our key markets of Japan and China. |
| Improving profitability. |
Our 2008 business plan is designed to increase profitability through revenue growth, improving gross margin, and reducing overhead. In the fourth quarter, we will execute additional operational modifications that we expect to improve our operating margin to 10.5 percent for 2008, significantly increasing our earnings per share. I believe that the changes we are making will allow us to accelerate earnings growth more than we have at any other time in our company history. Our commitment to this plan is evidenced by the $100 million addition to our share repurchase authorization announced this morning, concluded Hunt.
With a yen rate of 116 to the dollar, we expect fourth-quarter revenue of $295 to $300 million, said Ritch Wood, chief financial officer. We anticipate incurring restructuring charges during the quarter of $10 to $14 million, of which approximately $2 million are expected to be non-cash charges. Restructuring charges will be incurred primarily in the United States and China. Our tax rate, which will be impacted by FIN 48 and the restructuring charge in the fourth quarter, is estimated to be approximately 45 percent, negatively impacting earnings per share.
For 2008, we are modeling revenue to be $1.18 to $1.20 billion, assuming a yen rate of 115 to the dollar. With an operating margin of 10.5 percent, earnings per share are projected to be in the $1.15 to $1.22 range. We will provide more detailed modeling information during our annual investor conference today.
-more-
Nu Skin Enterprises
Nov. 5, 2007
Page 5
The companys annual investor conference will take place beginning at 9 a.m. (EST) at the New York Intercontinental Hotel. The event will be simultaneously webcast at www.nuskinenterprises.com. A replay of managements overview of the third quarter and 2008 guidance will be available Monday, Nov. 5, beginning at 1 p.m. (EST) on the Investor portion of the companys Web site, and will be available through Nov. 23, 2007.
Nu Skin Enterprises, Inc. is a global direct selling company operating in more than 40 markets throughout Asia, the Americas and Europe. The company markets premium-quality personal care products under the Nu Skin® brand, science-based nutritional supplements under the Pharmanex® brand, and technology-based products and services under the Big Planet® brand. Nu Skin Enterprises is traded on the New York Stock Exchange under the symbol NUS.
Nu Skin Enterprises press releases are available online at www.nuskinenterprises.com.
Please note: This press release, particularly the Outlook section, contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 that represent the companys current expectations and beliefs, including, among other things: (i) strategic objectives and initiatives for 2008; (ii) expectations regarding the positive impact of certain strategic initiatives and management changes on some of our key markets; and (iii) financial projections for the fourth quarter of 2007 and for 2008. The forward-looking statements and related assumptions involve risks and uncertainties that could cause actual results and outcomes to differ materially from any forward-looking statements or views expressed herein. These risks and uncertainties include, but are not limited to: (a) any inability of the company to effectively implement its planned strategic initiatives and the risk that such initiatives will not generate renewed or sustained revenue growth or generate interest among the companys distributors; (b) risks that could adversely impact the companys operations or financial results in its markets, including its largest market, Japan, such as negative market conditions, foreign currency exchange fluctuations, continued declines in executive-level and active distributors, or the companys failure to execute effective initiatives in these markets; (c) regulatory risks associated with the Companys products such as the Scanner, the Nu Skin ProDerm and the Galvanic Spa, which could inhibit the companys use of these products in a market if they are determined to be a medical device in any market or if regulatory scrutiny dampens enthusiasm or the ability of the company or its distributors to effectively utilize these tools; (d) continued regulatory scrutiny and investigations in Mainland China, which have from time to time, and could in the future, negatively impact the companys business, including the interruption of sales activities in stores and the imposition of fines; (e) risks that the direct selling regulations in China are interpreted or enforced by governmental authorities in a
-more-
Nu Skin Enterprises
Nov. 5, 2007
Page 6
manner that negatively impacts the companys current or planned business model there, including continued delays and uncertainty in the provincial direct selling licensing process, and risk that the implementation of a direct selling model will not result in the anticipated growth of the companys business in China given the restrictive nature of the direct selling laws; (f) any failure of current or planned initiatives or products, including, among others, the second-generation Scanner, the Nu Skin® ProDerm Skin Analyzer, Galvanic Spa System II and g3 juice, to generate interest among distributors and customers and generate sponsoring and selling activities on a sustained basis; (g) any inability of the company to obtain necessary product registrations for its nutritional and personal care products in a timely manner, increased regulatory scrutiny of nutritional products by regulators or changes in regulatory requirements that impact our products; (h) any failure of the implementation of recent business transformation initiatives and strategic initiatives in Brazil and other unprofitable markets to maintain profitability and drive growth; (i) adverse publicity related to the companys business, products or industry; (j) adverse results of tax audits and challenges by foreign tax authorities with respect to the amount of income tax, customs, duties and other amounts owed by the company; and (k) any inability of the Company to generate improvement in gross margins and reduce overhead through its strategic plans to improve operating efficiencies and the risk that there could be unanticipated expenses or business developments that negatively impact gross margins and overhead. The companys financial performance and the forward-looking statements contained herein are further qualified by a detailed discussion of associated risks set forth in the documents filed by the company with the Securities and Exchange Commission, including the companys Annual Report on Form 10-K filed on March 1, 2007 and Quarterly Reports on Form 10-Q filed on May 10, 2007 and August 9, 2007. The forward-looking statements set forth the companys beliefs as of the date of this release, and the company assumes no duty to update the forward-looking statements contained in this release to reflect any change, except as required by law.
(Financial tables to follow)
-more-
Nu Skin Enterprises
Nov. 5, 2007
Page 7
NU
SKIN ENTERPRISES, INC.
Consolidated
Statements of Income (Unaudited)
For the Third Quarters Ended September 30, 2007 and
2006
(in thousands, except
per share amounts)
2007 | 2006 | |||||
---|---|---|---|---|---|---|
Revenue: | ||||||
North Asia | $ 142,590 | $ 147,807 | ||||
Greater China | 51,993 | 51,039 | ||||
Americas | 52,482 | 40,506 | ||||
South Asia/Pacific | 25,514 | 22,653 | ||||
Europe | 18,132 | 14,340 | ||||
Total revenue | 290,711 | 276,345 | ||||
Cost of sales | 52,239 | 48,372 | ||||
Gross profit | 238,472 | 227,973 | ||||
Operating expenses: | ||||||
Selling expenses | 125,289 | 120,625 | ||||
General and administrative expenses | 93,963 | 86,337 | ||||
Total operating expenses | 219,252 | 206,962 | ||||
Operating income | 19,220 | 21,011 | ||||
Other income (expense), net | 6 | 220 | ||||
Income before provision for income taxes | 19,226 | 21,231 | ||||
Provision for income taxes | 5,681 | 8,013 | ||||
Net income | $ 13,545 | $ 13,218 | ||||
Net income per share: | ||||||
Basic | $ 0.21 | $ 0.19 | ||||
Diluted | $ 0.21 | $ 0.19 | ||||
Weighted average common shares outstanding: | ||||||
Basic | 64,616 | 69,630 | ||||
Diluted | 65,334 | 70,580 |
-more-
Nu Skin Enterprises
Nov. 5, 2007
Page 8
NU SKIN ENTERPRISES, INC.
Consolidated Statements of Income (Unaudited)
For the Nine-Month Periods Ended September 30, 2007 and 2006
(in thousands, except per share amounts)
2007 | 2006 | |||||
---|---|---|---|---|---|---|
Revenue: | ||||||
North Asia | $ 428,542 | $ 441,100 | ||||
Greater China | 153,045 | 156,883 | ||||
Americas | 140,270 | 121,955 | ||||
South Asia/Pacific | 74,137 | 64,502 | ||||
Europe | 55,598 | 41,796 | ||||
Total revenue | 851,592 | 826,236 | ||||
Cost of sales | 154,008 | 143,811 | ||||
Gross profit | 697,584 | 682,425 | ||||
Operating expenses: | ||||||
Selling expenses | 365,044 | 355,894 | ||||
General and administrative expenses | 274,745 | 265,127 | ||||
Impairment of assets and other | | 20,840 | ||||
Restructuring and other charges | | 11,115 | ||||
Total operating expenses | 639,789 | 652,976 | ||||
Operating income | 57,795 | 29,449 | ||||
Other income (expense), net | 109 | (2,241 | ) | |||
Income before provision for income taxes | 57,904 | 27,208 | ||||
Provision for income taxes | 20,067 | 10,255 | ||||
Net income | $ 37,837 | $ 16,953 | ||||
Net income per share: | ||||||
Basic | $ 0.58 | $ 0.24 | ||||
Diluted | $ 0.57 | $ 0.24 | ||||
Weighted average common shares outstanding: | ||||||
Basic | 65,022 | 69,986 | ||||
Diluted | 65,845 | 70,934 |
-more-
Nu Skin Enterprises
Nov. 5, 2007
Page 9
NU SKIN ENTERPRISES,
INC.
Consolidated Balance Sheets
(Unaudited)
(in thousands)
September 30, 2007 | December 31, 2006 | ||||
---|---|---|---|---|---|
ASSETS | |||||
Current assets: | |||||
Cash and cash equivalents | $ 118,024 | $ 121,353 | |||
Accounts receivable | 26,822 | 19,421 | |||
Short term investments | 7,700 | | |||
Inventories, net | 97,550 | 92,092 | |||
Prepaid expenses and other | 43,752 | 44,093 | |||
293,848 | 276,959 | ||||
Property and equipment, net | 88,789 | 85,883 | |||
Goodwill | 112,446 | 112,446 | |||
Other intangible assets, net | 87,912 | 91,349 | |||
Other assets | 136,476 | 98,212 | |||
Total assets | $ 719,471 | $ 664,849 | |||
LIABILITIES AND STOCKHOLDERS' EQUITY | |||||
Current liabilities: | |||||
Accounts payable | $ 28,293 | $ 20,815 | |||
Accrued expenses | 110,359 | 120,074 | |||
Current portion of long-term debt | 31,988 | 26,652 | |||
170,640 | 167,541 | ||||
Long-term debt | 183,112 | 136,173 | |||
Other liabilities | 67,994 | 42,155 | |||
Total liabilities | 421,746 | 345,869 | |||
Stockholders' equity: | |||||
Class A common stock | 91 | 91 | |||
Additional paid-in capital | 205,982 | 199,322 | |||
Treasury stock, at cost | (390,195 | ) | (346,889 | ) | |
Retained earnings | 547,471 | 531,563 | |||
Accumulated other comprehensive loss | (65,624 | ) | (65,107 | ) | |
297,725 | 318,980 | ||||
Total liabilities and stockholders' equity | $ 719,471 | $ 664,849 |
-more-
Nu Skin Enterprises
Nov. 5, 2007
Page 10
As of September 30, 2007 | As of September 30, 2006 | % Increase (Decrease) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Active* | Executive | Active* | Executive | Active* | Executive | ||||||||
North Asia | 324,000 | 14,621 | 329,000 | 14,863 | (1.5%) | (1.6%) | |||||||
Greater China | 144,000 | 6,249 | 155,000 | 6,246 | (7.1%) | | |||||||
Americas | 155,000 | 4,469 | 152,000 | 3,970 | 2.0% | 12.6% | |||||||
South Asia/Pacific | 67,000 | 2,177 | 74,000 | 2,093 | (9.5%) | 4.0% | |||||||
Europe | 54,000 | 1,830 | 47,000 | 1,408 | 14.9% | 30.0% | |||||||
Total | 744,000 | 29,346 | 757,000 | 28,580 | (1.7%) | 2.7% |
* | Active distributors include preferred customers and distributors purchasing products directly from the company during the quarter. |